Download PDF
Thromb Haemost 2009; 102(06): 1289-1291
DOI: 10.1160/TH09-03-0187
Letters to the Editor
Schattauer GmbH

Effect of cigarette smoking on plasma fibrin clot permeability and susceptibility to lysis

Anetta Undas
1   Institute of Cardiology, Jagiellonian University School of Medicine, Krakow, Poland
,
Roman Topór-Madry
2   Institute of Public Health Jagiellonian University School of Medicine, Krakow, Poland
,
Wieslawa Tracz
1   Institute of Cardiology, Jagiellonian University School of Medicine, Krakow, Poland
,
Mieczyslaw Pasowicz
3   John Paul II Hospital, Krakow, Poland
› Author AffiliationsFinancial support: This work was supported by a grant of the Polish Ministry of Science and Education (to A. Undas).
Further Information

Publication History

Received: 21 March 2009

Accepted after major revision: 04 September 2009

Publication Date:
28 November 2017 (online)

Also available at
    Permissions and Reprints

 

 

  • References

  • 1 Tapson VF. The role of smoking in coagulation and thromboembolism in chronic obstructive pulmonary disease. Proc Am Thorac Soc 2005; 02: 71-77.
    CrossrefPubMedGoogle Scholar
  • 2 Scott EM, Ariëns RAS, Grant PJ. Genetic and environmental determinants of fibrin structure and function. Relevance to clinical disease. Arterioscler Thromb Vasc Biol 2004; 24: 1558-1566.
    CrossrefPubMedGoogle Scholar
  • 3 Undas A, Celinska-Lowenhoff M, Lowenhoff T. et al. Statins, fenofibrate, and quinapril increase clot permeability and enhance fibrinolysis in patients with coronary artery disease. J Thromb Haemost 2006; 04: 1029-1036.
    CrossrefPubMedGoogle Scholar
  • 4 Sjoland JA, Sidelmann JJ, Brabrand M. et al. Fibrin clot structure in patients with end-stage renal disease. Thromb Haemost 2007; 98: 339-345.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 5 Undas A, Szuldrzynski K, Stepien E. et al. Reduced clot permeability and susceptibility to lysis in patients with acute coronary syndrome: effects of inflammation and oxidative stress. Atherosclerosis 2007; 196: 551-558.
    PubMedGoogle Scholar
  • 6 Hoffman M. Alterations of fibrinogen structure in human disease. Cardiovasc Hematol Agents Medicinal Chem 2008; 06: 161-180.
    PubMedGoogle Scholar